Research work · 2019

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell, Guillem Argilés, Niall Christopher Tebbutt, Maria Di Bartolomeo, Alfredo Falcone, Marwan Fakih, Mark F. Kozloff, Neil Howard Segal, Alberto Felice Sobrero, Yibing Yan, Ilsung Chang, Anne R. Uyei, Louise Roberts, Fortunato Ciardiello, JB Ahn, Jamil Asselah, Suprith Badarinath, Shobhit Baijal

The Lancet Oncology

Read free full text

DOI: 10.1016/s1470-2045(19)30027-0